Tara Health Foundation, a long-term shareholder in Pfizer Inc., has submitted a proxy memorandum urging shareholders to vote in favor of Item No. 6, which calls for Pfizer to publish an annual congruency report. This report would analyze the alignment of Pfizer's political, lobbying, and electioneering expenditures with its publicly stated values and policies, particularly regarding gender equality and reproductive health. The memorandum, dated April 16, 2024, highlights discrepancies between Pfizer's support for reproductive rights and gender equality and its political contributions to candidates and organizations that oppose such policies. The Tara Health Foundation argues that Pfizer's political spending appears misaligned with its stated values, potentially threatening the company's reputation and bottom line. The foundation emphasizes the importance of transparency and accountability in corporate political spending, noting that other companies have begun publishing congruency reports as a best practice. Pfizer's shareholders are encouraged to vote 'Yes' on Item No. 6 to promote responsible political spending that aligns with the company's values and business interests.

Tara Health Foundation, a long-term shareholder in Pfizer Inc., has submitted a proxy memorandum urging shareholders to vote in favor of Item No. 6, which calls for Pfizer to publish an annual congruency report. This report would analyze the alignment of Pfizer's political, lobbying, and electioneering expenditures with its publicly stated values and policies, particularly regarding gender equality and reproductive health. The memorandum, dated April 16, 2024, highlights discrepancies between Pfizer's support for reproductive rights and gender equality and its political contributions to candidates and organizations that oppose such policies. The Tara Health Foundation argues that Pfizer's political spending appears misaligned with its stated values, potentially threatening the company's reputation and bottom line. The foundation emphasizes the importance of transparency and accountability in corporate political spending, noting that other companies have begun publishing congruency reports as a best practice. Pfizer's shareholders are encouraged to vote 'Yes' on Item No. 6 to promote responsible political spending that aligns with the company's values and business interests.